MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    PARKinSOUND: Impact of participation in an orchestra in patients with Parkinson’s disease

    S. Marques, S. Lopes, A. Ferreira, A. Silva, G. Carneiro, S. Varanda, P. Santos, A. Goios, M. Rodrigues (Braga, Portugal)

    Objective: To investigate the impact of participation in a community orchestra on motor and non-motor symptoms in PD patients. Background: Music undoubtfully contributes to our…
  • 2023 International Congress

    Space-occupying lesion presenting with hand dystonia

    S. Lopes, M. Santos, R. Pereira, M. Cambango, L. Oliveira, S. Varanda (Braga, Portugal)

    Objective: To report the case of a patient diagnosed with a solitary fibrous tumor located on the foramen magnum that presented with hand dystonia Background:…
  • 2023 International Congress

    Adequate hydration with personalized diet improves bowel function and mobility for people with Parkinson’s (PwP’s) on levodopa/carbidopa intestinal gel (LCIG) infusion therapy

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To investigate the effect of the adequate hydration with personalized diet on bowel function, motor function, and global function in PwP’s on LCIG. Background:…
  • 2023 International Congress

    Sleep-Wake Dependent Modulation in Pallidal Beta and High-Frequency Oscillations in Parkinson’s Disease

    A. Verma, S. Acosta-Lenis, J. Aman, J. Wang, A. Pearson, M. Hill, R. Patriat, S. Cooper, M. Park, N. Harel, M. Howell, C. Mackinnon, J. Vitek, L. Johnson (Minneapolis, USA)

    Objective: To characterize the dynamics of oscillatory activity in the globus pallidus internus (GPi) across the sleep-wake cycle in people with Parkinson’s disease (PD) with…
  • 2023 International Congress

    Long term treatment with botulinum neurotoxin for focal dystonia – effect of dose and dilution

    D. Weise, P. Henn, C. Weise (Stadtroda, Germany)

    Objective: To evaluate the efficacy and safety of the higher dilution rates of Botulinum neurotoxin (BoNT) in focal dystonia. Background: BoNT is the first line…
  • 2023 International Congress

    Factors influencing voice function after deep brain stimulation in Parkinson’s disease

    H. Jergas, T. Tsuboi, V. Stopic, D. Nakatsubo, C. Hennen, S. Maesawa, J. Einhaus, R. Saito, V. Visser-Vandewalle, M. Katsuno, M. Barbe (Cologne, Germany)

    Objective: To assess the effect of Deep Brain Stimulation (DBS) on self-perceived changes of voice function in Parkinson’s disease (PD). Background: To date, the effect…
  • 2023 International Congress

    A forgotten cause of ocular motor apraxia

    C. Azoia, C. Silva, A. Velon, A. Raimundo (Vila Real, Portugal)

    Objective: To report an example of the rare association between acquired hepatocerebral degeneration (AHD) and ocular motor apraxia (OA), and discuss its relevance for topical…
  • 2023 International Congress

    The effects of dopaminergic treatment on interhemispheric disinhibition and bradykinesia asymmetry in Parkinson’s disease

    M. de Riggi, G. Paparella, M. Bologna, D. Colella, A. Cannavacciuolo, A. de Biase, D. Birreci, D. Costa, A. Guerra, A. Berardelli (Rome, Italy)

    Objective: to investigate whether dopaminergic therapy modulates IHI and bradykinesia asymmetry in PD. Background: previous evidence demonstrated a reduced interhemispheric inhibition (IHI) in Parkinson’s disease…
  • 2023 International Congress

    A minimal clinically important difference for UHDRS® Total Maximal Chorea score as a measure of chorea severity in Huntington disease

    E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, H. Zhang, O. Klepitskaya, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To establish a minimal clinically important difference (MCID) for the Unified Huntington Disease Rating Scale (UHDRS®) Total Maximal Chorea (TMC) score as a measure…
  • 2023 International Congress

    First Case Series on the use of a High Frequency Vibrotactile Stimulation and Cueing Device in Panama

    R. Rodriguez, L. Pinilla, J. Villarreal (Panama, Panama)

    Objective: To assess the use of Focussed Vibrotactile Stimulation and Cueing Device (FVCD) in two patients with Parkinson's disease (PD) Background: We present two patients…
  • « Previous Page
  • 1
  • …
  • 606
  • 607
  • 608
  • 609
  • 610
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley